carbocysteine-lysine has been researched along with Pulmonary Disease, Chronic Obstructive in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flore, MC; Graziani, C; Lanata, L; Palermo, P; Paone, G; Puglisi, G; Ramaccia, M; Saibene, F; Toti, S | 1 |
| Bocchino, M; Bruzzese, D; Esposito, A; Ponticiello, A; Sanduzzi, A; Stanziola, A; Valentino, MR | 1 |
| Calvert, J; Hooper, C | 1 |
| Carpagnano, GE; Di Gioia, G; Foschino-Barbaro, MP; Gramiccioni, E; Resta, O; Serviddio, G; Spanevello, A; Stefano, A | 1 |
| Barbieri, A; Chicca, M; Ciaccia, A; Daffonchio, L; Leis, M; Novellini, R; Pinamonti, S; Ravenna, F; Sostero, S; Venturoli, L | 1 |
1 review(s) available for carbocysteine-lysine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease.
Topics: Animals; Anti-Inflammatory Agents; Carbocysteine; Clinical Trials as Topic; Drug Administration Schedule; Expectorants; Free Radical Scavengers; Humans; Oxidative Stress; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2008 |
1 trial(s) available for carbocysteine-lysine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys).
Topics: Adult; Carbocysteine; Dinoprost; Exhalation; Female; Humans; Interleukin-6; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Time Factors; Treatment Outcome | 2004 |
3 other study(ies) available for carbocysteine-lysine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
A prospective study of the effects of carbocysteine lysine salt on frequency of exacerbations in COPD patients treated with or without inhaled steroids.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Bronchodilator Agents; Carbocysteine; Drug Administration Schedule; Drug Therapy, Combination; Expectorants; Female; Glucocorticoids; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Severity of Illness Index; Symptom Flare Up; Treatment Outcome | 2019 |
Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study.
Topics: Aged; Bronchodilator Agents; Carbocysteine; Expectorants; Female; Humans; Italy; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Smoking; Spirometry; Time Factors | 2016 |
Antioxidant activity of carbocysteine lysine salt monohydrate.
Topics: Aged; Aged, 80 and over; Antioxidants; Carbocysteine; Cells, Cultured; DNA Damage; Female; Glutathione; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive | 2001 |